Kazia Therapeutics (KZIA) Total Current Liabilities (2009 - 2025)
Kazia Therapeutics (KZIA) posted Total Current Liabilities of $16.0 million for Q4 2025, up 77.81% on a QoQ basis from $9.0 million in Q2 2025, and up 48.2% year-over-year from $10.8 million in Q4 2024.
Kazia Therapeutics (KZIA) Total Current Liabilities (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $16.0 million for Q4 2025.
- Quarterly Total Current Liabilities rose 48.2% year-over-year to $16.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.0 million (up 48.2% YoY) and the FY2025 annual result came in at $9.0 million, down 47.06% from the prior year.
- Total Current Liabilities was $16.0 million for Q4 2025 at Kazia Therapeutics, up from $9.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $17.0 million in Q2 2024 and bottomed at $3.7 million in Q4 2022.
- A 5-year average of $8.6 million and a median of $6.9 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities jumped 236.24% — and 2025, when it sank 47.06%.
- Kazia Therapeutics' Total Current Liabilities stood at $5.5 million in 2021, then tumbled by 33.7% to $3.7 million in 2022, then jumped by 101.2% to $7.4 million in 2023, then soared by 46.33% to $10.8 million in 2024, then surged by 48.2% to $16.0 million in 2025.
- Business Quant data shows KZIA's Total Current Liabilities at $16.0 million in Q4 2025, $9.0 million in Q2 2025, and $10.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 16.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.00 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Dec 31, 2024 | 10.80 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Jun 30, 2023 | 5.06 Mn |
| Dec 31, 2022 | 3.67 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Dec 31, 2021 | 5.53 Mn |
| Jun 30, 2021 | 6.41 Mn |
| Dec 31, 2020 | 1.99 Mn |
| Jun 30, 2020 | 3.32 Mn |
| Dec 31, 2019 | 2.11 Mn |
| Jun 30, 2019 | 1.33 Mn |
| Dec 31, 2018 | 1.74 Mn |
| Jun 30, 2018 | 2.94 Mn |
| Jun 30, 2017 | 4.04 Mn |
| Dec 31, 2016 | 5.29 Mn |
| Jun 30, 2016 | 4.02 Mn |
| Dec 31, 2015 | 1.28 Mn |